Chyme reinfusion practices in the neonatal population
Topic overview
This retrospective study examines chyme reinfusion therapy (CRT) in 49 neonates with stomas, finding that nearly half received CRT with significant improvements in weight gain. The practice involves refeeding proximal stoma output into the distal bowel to promote intestinal adaptation, though standardized protocols are needed to increase utilization in this underserved population.
Key takeaways
- Chyme reinfusion therapy significantly improved weight gain in neonates (13.9 to 24.37 g/day, p=0.04) with intestinal stomas.
- CRT is underutilized: only 47% of eligible neonates received therapy despite proven nutritional benefits and safety profile.
- Common non-infectious complications (skin irritation 60%, prolapse 43%) were related to stoma presence, not CRT itself.
- Standardized CRT protocols with clear eligibility criteria are needed to increase adoption in neonatal intestinal failure.
- CRT mimics intestinal continuity by refeeding proximal output into distal limb, promoting bowel adaptation pre-reversal.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Chyme reinfusion practices in the neonatal population. GlobalCastMD Medical Library. 2024-11-27. https://dev.library.globalcastmd.com/article/9463?via_space=staycurrentmd
Comments